|Cat #||Size||Price||Quantity Check Availability||Save|
Bioinformatic homology analysis reveals that Oncostatin M, also known as OSM, has a similar composition and structure as LIF, G-CSF, and IL-6. This suggests that these genes were derived by duplication of a common ancestral gene. In fact, many of its biological functions are shared with LIF. The receptor systems for OSM differ in composition between man and mouse. Human OSM binds two types of OSM receptor (OSMR) complexes. The type I receptor complex is composed of gp130 (IL-6 signal transducer) and LIF receptor β (LIFRβ) subunits. The type II receptor is constituted by the gp130 receptor and the OSMR β-chain. The murine ortholog, which has high affinity binding sites, binds only to the type II OSMR/gp130 receptor complex. Human OSM efficiently activates signal transduction in murine cells; nevertheless, it utilizes only the type I LIFR/gp130 heterodimer on these cells. However, mouse OSM is unable to stimulate human cells. OSM shares the OSMRβ-chain with the IL-31 receptor complex. The OSMRβ subunit is expressed by fibroblasts, endothelial, hepatic, lung, and hematopoietic cells. Pro inflammatory properties of OSM have been reported in the skin, adipose tissue, lung, heart, and liver. OSM triggers acute phase protein synthesis on hepatocytes. OSM is a potent inhibitor of keratinocyte proliferation and decreases the expression of both early and late keratinocyte differentiation markers. OSM transcripts are elevated in skin from psoriasis and atopic dermatitis patients, as compared with healthy skin. OSM and its receptor complexes play a key role in cutaneous inflammatory responses. In addition, OSM expression is increased in colonic biopsies of patients with active inflammatory bowel disease.Product Details
- Mouse Oncostatin M, amino acids (Ala24-Arg206) (Accession# NP_001013383) was expressed in E.coli. The amino terminus contains Met.
- Molecular Mass
- The 184 amino acid recombinant protein has a predicted molecular mass of approximately 20.7 kD. The DTT-reduced and non-reduced protein migrate at approximately 17 kD and 22 kD, respectively, by SDS-PAGE. The predicted N-terminal amino acid is Met.
- > 95% by SDS-PAGE gel as determined by Coomassie stained SDS-PAGE.
- 0.22 µm filtered protein solution is in PBS pH7.2.
- Endotoxin Level
- Less than 0.01 ng/ per µg cytokine (0.1 EU/ µg) as determined by the LAL method.
- 10 and 25 µg sizes are bottled at 200 µg/mL. 100 µg size and larger sizes are lot-specific and bottled at the concentration indicated on the vial (please contact technical support for concentration, or use our Lookup tool if you have a lot number.) Please note, new lots of the 100 µg size will be lot-specific and may differ from previous lots that had a fixed concentration.
- Storage & Handling
- Unopened vial can be stored between 2°C and 8°C for up to 2 weeks, at -20°C for up to six months, or at -70°C or colder until the expiration date. For maximum results, quick spin vial prior to opening. The protein can be aliquoted and stored at -20°C or colder. Stock solutions can also be prepared at 50 - 100 µg/mL in appropriate sterile buffer, carrier protein such as 0.2 - 1% BSA or HSA can be added when preparing the stock solution. Aliquots can be stored between 2°C and 8°C for up to one week and stored at -20°C or colder for up to 3 months. Avoid repeated freeze/thaw cycles.
- Mouse Oncostatin M induces the proliferation of murine NIH 3T3 cells. The ED50 = 0.25 — 1.5 ng/ml.
- Recommended Usage
- Application Notes
BioLegend carrier-free recombinant proteins provided in liquid format are shipped on blue-ice. Our comparison testing data indicates that when handled and stored as recommended, the liquid format has equal or better stability and shelf-life compared to commercially available lyophilized proteins after reconstitution. Our liquid proteins are verified in-house to maintain activity after shipping on blue ice and are backed by our 100% satisfaction guarantee. If you have any concerns, contact us at email@example.com.
- Product Citations
- Activated monocyte, macrophages, T-lymphocyte, skin-infiltrating T cells, and dendritic cells.
- Proinflammatory mediator, keratinocyte activator, induces acute phase protein synthesis, hematopoiesis, bone remodeling, angiogenesis, and cardiac remodeling.
- Keratinocytes, fibroblasts, endothelial, hepatic, lung, hematopoietic cells, epithelial cells, and smooth muscle cells.
- Type II OSMR/gp130 receptor complex.
- Cell Type
- Hematopoietic stem and progenitors, Embryonic Stem Cells
- Biology Area
- Cell Proliferation and Viability, Stem Cells, Immunology
- Molecular Family
- Cytokines/Chemokines, Growth Factors
- Antigen References
1. Lindberg RA, et al. 1998. Mol. Cell. Biol. 18:3357.
2. Rose TM, Bruce AG. 1991. Proc. Natl. Acad. Sci. USA 88:8641.
3. Mosley B, et al. 1996. J. Biol. Chem. 271:32635.
4. Dillon SR, et al. 2004. Nat. Immunol. 5:752.
5. Boniface K, et al. 2007. J. Immunol. 178:4615.
6. Drechsler J, et al. 2012. PLoS One 7(8):e43155.
7. Beigel F, et al. 2014. PLoS One 9(4):e93498.
8. Schnittker D, et al. 2013. Mediators Inflamm. 2013:317503.
- Gene ID
- 18413 View all products for this Gene ID
- View information about Oncostatin M on UniProt.org
- Why choose BioLegend recombinant proteins?
• Each lot of product is quality-tested for bioactivity as indicated on the data sheet.
• Greater than 95% Purity or higher, tested on every lot of product.
• 100% Satisfaction Guarantee for quality performance, stability, and consistency.
• Ready-to-use liquid format saves time and reduces challenges associated with reconstitution.
• Bulk and customization available. Contact us.
• Learn more about our Recombinant Proteins.
- How does the activity of your recombinant proteins compare to competitors?
We quality control each and every lot of recombinant protein. Not only do we check its bioactivity, but we also compare it against other commercially available recombinant proteins. We make sure each recombinant protein’s activity is at least as good as or better than the competition’s. In order to provide you with the best possible product, we ensure that our testing process is rigorous and thorough. If you’re curious and eager to make the switch to BioLegend recombinants, contact your sales representative today!
- What is the specific activity or ED50 of my recombinant protein?
The specific activity range of the protein is indicated on the product datasheets. Because the exact activity values on a per unit basis can largely fluctuate depending on a number of factors, including the nature of the assay, cell density, age of cells/passage number, culture media used, and end user technique, the specific activity is best defined as a range and we guarantee the specific activity of all our lots will be within the range indicated on the datasheet. Please note this only applies to recombinants labeled for use in bioassays. ELISA standard recombinant proteins are not recommended for bioassay usage as they are not tested for these applications.
- Have your recombinants been tested for stability?
Our testing shows that the recombinant proteins are able to withstand room temperature for a week without losing activity. In addition the recombinant proteins were also found to withstand four cycles of freeze and thaw without losing activity.
- Does specific activity of a recombinant protein vary between lots?
Specific activity will vary for each lot and for the type of experiment that is done to validate it, but all passed lots will have activity within the established ED50 range for the product and we guarantee that our products will have lot-to-lot consistency. Please conduct an experiment-specific validation to find the optimal ED50 for your system.
- How do you convert activity as an ED50 in ng/ml to a specific activity in Units/mg?
- Use formula Specific activity (Units/mg) = 10e6/ ED50 (ng/mL)